Analyst Expectations For Stoke Therapeutics's Future
Analyst Expectations For Stoke Therapeutics's Future
分析師對Stoke Therapeutics未來的預期
Stoke Therapeutics (NASDAQ:STOK) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Stoke Therapeutics（納斯達克股票代碼：STOK）在上個季度接受了8位分析師的分析，揭示了從看漲到看跌的一系列觀點。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表總結了他們最近的評估，說明了過去30天不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts have recently evaluated Stoke Therapeutics and provided 12-month price targets. The average target is $20.75, accompanied by a high estimate of $35.00 and a low estimate of $13.00. Witnessing a positive shift, the current average has risen by 62.75% from the previous average price target of $12.75.
分析師最近對Stoke Therapeutics進行了評估，並提供了12個月的目標股價。平均目標爲20.75美元，最高估計值爲35.00美元，低估值爲13.00美元。當前的平均價格從之前的平均目標股價12.75美元上漲了62.75％，這是一個積極的轉變。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析師評級：全面細分
A comprehensive examination of how financial experts perceive...
對金融專家如何看...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。